PCA
GPCR icon

Private Capital Advisors’s Structure Therapeutics GPCR Stock Holding History

Private Capital Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
29,760
-4,629
-13% -$205K 0.14% 36
2026
Q1 		$1.66M Buy
34,389
+27,041
+368% +$1.85M 0.19% 35
2025
Q4 		$511K Sell
7,348
-47,837
-87% -$1.95M 0.05% 52
2025
Q3 		$1.55M Buy
+55,185
New +$1.1M 0.17% 39

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Private Capital Advisors's GPCR Position: Q2 2026 in Review

Private Capital Advisors reduced its Structure Therapeutics (GPCR) stake by 13% in Q2 2026, selling an estimated $205K and leaving 29,760 shares worth $1.6M. The position accounts for 0.14% of the portfolio, ranked #36.

Private Capital Advisors first reported a position in GPCR in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.66M in Q1 2026. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Private Capital Advisors held 29,760 shares of Structure Therapeutics worth $1.6M as of Q2 2026.
  • Private Capital Advisors sold 4,629 Structure Therapeutics shares in Q2 2026, an estimated $205K.
  • Structure Therapeutics made up 0.14% of Private Capital Advisors's portfolio in Q2 2026, its #36 holding.
  • Private Capital Advisors first reported a position in Structure Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Private Capital Advisors's Structure Therapeutics position peaked at $1.66M in Q1 2026.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.